IN RE: Aflibercept Patent Litigation
Plaintiff: Liaison Counsel for Plaintiffs
Defendant: Liaison Counsel for Defendants
Case Number: MDL NO. 3103
Filed: January 11, 2024
Court: Judicial Panel on Multidistrict Litigation
Nature of Suit: Other
RSS RSS Track this Docket
Docket Report

This docket was last retrieved on March 5, 2024. A more recent docket listing may be available from PACER.

Date Filed Document Text
March 5, 2024 Filing 39 NOTICE OF PRESENTATION OF ORAL ARGUMENT re: pldg. ( #32 in MDL No. 3103, 15 in WVN/1:23-cv-00097), ( #24 in MDL No. 3103, 10 in WVN/1:23-cv-00097) Filed by Terri L. Mascherin on behalf of Defendant Formycon AG Associated Cases: MDL No. 3103, WVN/1:23-cv-00097 (DLD)
March 5, 2024 Filing 38 NOTICE OF PRESENTATION OF ORAL ARGUMENT re: pldg. ( #32 in MDL No. 3103, 16 in WVN/1:22-cv-00061), ( #26 in MDL No. 3103, 12 in WVN/1:22-cv-00061) Filed by Deanne Mazzochi on behalf of Defendants BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc. (Attachments: #1 Proof of Service) Associated Cases: MDL No. 3103, WVN/1:22-cv-00061 (DLD)
March 4, 2024 Filing 37 ORAL ARGUMENT STATEMENT re: pldg. ( #27 in MDL No. 3103, #32 in MDL No. 3103) Filed by Defendant Amgen, Inc.. (Attachments: #1 Exhibit, #2 Schedule of Actions, #3 Proof of Service) Associated Cases: MDL No. 3103, CAC/2:24-cv-00264 (Gutman, Siegmund) Modified on 3/5/2024 (LH). ADDED MDL LINK Modified on 3/6/2024 (DLD). EDITED EVENT TYPE AND EDITED MDL LINK.
March 4, 2024 Filing 36 NOTICE OF PRESENTATION OF ORAL ARGUMENT re: pldg. (17 in CAC/2:24-cv-00264), ( #32 in MDL No. 3103) Filed by Siegmund Y. Gutman on behalf of Defendant Amgen, Inc. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 3103, CAC/2:24-cv-00264 (Gutman, Siegmund) Modified on 3/5/2024 (RH). ADDED MDL LINK
March 4, 2024 Filing 35 NOTICE OF PRESENTATION OF ORAL ARGUMENT re: pldg. (15 in WVN/1:23-cv-00106), ( #32 in MDL No. 3103) Filed by Max Gottlieb on behalf of Defendant Celltrion, Inc. (Attachments: #1 Proof of Service) Associated Cases: MDL No. 3103, CAC/2:24-cv-00264, WVN/1:22-cv-00061, WVN/1:23-cv-00089, WVN/1:23-cv-00094, WVN/1:23-cv-00097, WVN/1:23-cv-00106 (Gottlieb, Max) Modified on 3/5/2024 (RH). ADDED MDL LINK
March 4, 2024 Filing 34 NOTICE OF PRESENTATION OF ORAL ARGUMENT re: pldg. ( #24 in MDL No. 3103, 10 in WVN/1:23-cv-00094, 10 in WVN/1:23-cv-00106), ( #32 in MDL No. 3103) Filed by Matthew A Traupman on behalf of Defendant Samsung Bioepis, CO., LTD. (Attachments: #1 Appendix, #2 Proof of Service) Associated Cases: MDL No. 3103, WVN/1:23-cv-00094, WVN/1:23-cv-00106 (Traupman, Matthew) Modified on 3/5/2024 (RH). ADDED MDL LINK AND DELETED DUPLICATE PARTY NAMES
March 4, 2024 Filing 33 NOTICE OF PRESENTATION OF ORAL ARGUMENT re: pldg. (17 in CAC/2:24-cv-00264, #32 in MDL No. 3103, 16 in WVN/1:22-cv-00061, 18 in WVN/1:23-cv-00089, 15 in WVN/1:23-cv-00094, 15 in WVN/1:23-cv-00097, 15 in WVN/1:23-cv-00106), ( #1 in MDL No. 3103) Filed by David Isaac Berl on behalf of Plaintiff Regeneron Pharmaceuticals, Inc. (Attachments: #1 Schedule of Actions Schedule of Actions, #2 Proof of Service Proof of Service) Associated Cases: MDL No. 3103, CAC/2:24-cv-00264, WVN/1:22-cv-00061, WVN/1:23-cv-00089, WVN/1:23-cv-00094, WVN/1:23-cv-00097, WVN/1:23-cv-00106 (Berl, David) Modified on 3/5/2024 (RH). DELETED DUPLICATE PARTY NAMES
February 16, 2024 Opinion or Order Filing 32 HEARING ORDER re: pldg. ( #1 in MDL No. 3103) - SECTION A (DESIGNATED FOR ORAL ARGUMENT) PANEL HEARING set for 3/28/2024 in Charleston, South Carolina. Notices of Presentation or Waiver of Oral Argument due on or before 3/4/2024.#Notice of Presentation or Waiver of Oral Argument form (JPML form 9) can be downloaded from our website.Signed by Judge Karen K. Caldwell, Chair, PANEL ON MULTIDISTRICT LITIGATION, on 2/16/2024. (Attachments: #1 Courthouse Advisory) Associated Cases: MDL No. 3103, CAC/2:24-cv-00264, WVN/1:22-cv-00061, WVN/1:23-cv-00089, WVN/1:23-cv-00094, WVN/1:23-cv-00097, WVN/1:23-cv-00106 (RH)
February 12, 2024 Filing 31 MINUTE ORDER CLOSING BRIEFING re: pldg. ( #1 in MDL No. 3103), ( #2 in MDL No. 3103) Briefing in this matter is now closed. The parties to actions on the motion(s) remain under a duty, pursuant to Panel Rules 6.1(f) and 6.2(d), to notify the Clerk of the Panel promptly of potential tag-along actions, as well as any development that moots the motion or fully disposes of any action on the motion. Parties in any potential tag-along action may file an Interested Party response, but must do so promptly, and in any event, no later than the Thursday prior to the hearing session at which the motion for transfer is to be heard by the Panel.Signed by Clerk of the Panel Tiffaney D. Pete on 2/12/2024. Associated Cases: MDL No. 3103, CAC/2:24-cv-00264, WVN/1:22-cv-00061, WVN/1:23-cv-00089, WVN/1:23-cv-00094, WVN/1:23-cv-00097, WVN/1:23-cv-00106 (LH)
February 12, 2024 Filing 30 ERRATA - to (10 in CAC/2:24-cv-00264, #24 in MDL No. 3103, 11 in WVN/1:22-cv-00061, 12 in WVN/1:23-cv-00089, 10 in WVN/1:23-cv-00094, 10 in WVN/1:23-cv-00097, 10 in WVN/1:23-cv-00106) - Filed by Defendants Formycon AG, #et al.Samsung Bioepis, CO., LTD.,, Celltrion, Inc., Samsung Bioepis Co., Ltd. #[Suppress List] (Attachments: #1 Corrected Response in Opposition (Joint), #2 Proof of Service) Associated Cases: MDL No. 3103, CAC/2:24-cv-00264, WVN/1:22-cv-00061, WVN/1:23-cv-00089, WVN/1:23-cv-00094, WVN/1:23-cv-00097, WVN/1:23-cv-00106 (Traupman, Matthew)
February 9, 2024 Filing 29 REPLY TO RESPONSE TO MOTION FOR TRANSFER re: pldg. ( #1 in MDL No. 3103), ( #24 , #26 , #27 in MDL No. 3103) Filed by Plaintiff Regeneron Pharmaceuticals, Inc. (Attachments: #1 Exhibit 8, #2 Exhibit 9, #3 Exhibit 10, #4 Exhibit 11, #5 Exhibit 12, #6 Exhibit 13, #7 Exhibit 14, #8 Exhibit 15, #9 Schedule of Actions, #10 Proof of Service) Associated Cases: MDL No. 3103, CAC/2:24-cv-00264, WVN/1:22-cv-00061, WVN/1:23-cv-00089, WVN/1:23-cv-00094, WVN/1:23-cv-00097, WVN/1:23-cv-00106 (Berl, David) Modified on 2/12/2024 (LH). ADDED MDL LINKS, REMOVED DUPLCIATE PARTIES AND DUPLICATE ATTACHMENT NAMES
February 8, 2024 Filing 28 ERRATA - to (12 in CAC/2:24-cv-00264, #27 in MDL No. 3103) - Filed by Defendant Amgen, Inc. (Attachments: #1 Other Corrected MDL Opposition, #2 Corrected Schedule of Actions, #3 Proof of Service) Associated Cases: MDL No. 3103, CAC/2:24-cv-00264 (Gutman, Siegmund) Modified on 2/9/2024 (LH). REMOVED DUPLICATE ATTACHMENT NAMES
February 2, 2024 Filing 27 RESPONSE IN OPPOSITION -- (re: pldg. ( #1 in MDL No. 3103) ) Filed by Defendant Amgen, Inc. (Attachments: #1 Schedule of Actions, #2 Proof of Service, #3 Exhibit 1, #4 Exhibit 2, #5 Exhibit 3, #6 Exhibit 4, #7 Exhibit 5, #8 Exhibit 6, #9 Exhibit 7, #10 Exhibit 8, #11 Exhibit 9, #12 Exhibit 10, #13 Exhibit 11, #14 Exhibit 12) Associated Cases: MDL No. 3103, CAC/2:24-cv-00264 (Gutman, Siegmund)
February 2, 2024 Filing 26 RESPONSE IN OPPOSITION -- (re: pldg. ( #1 in MDL No. 3103) ) Filed by Defendants/Counter Claimants BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc. (Attachments: #1 Exhibit Exhibit 1 - Disclaimer, #2 Proof of Service) Associated Cases: MDL No. 3103, CAC/2:24-cv-00264, WVN/1:22-cv-00061, WVN/1:23-cv-00089, WVN/1:23-cv-00094, WVN/1:23-cv-00097, WVN/1:23-cv-00106 (Mazzochi, Deanne) Modified on 2/6/2024 (LH). REMOVED DUPLICATE PARTIES
February 2, 2024 Filing 25 CORPORATE DISCLOSURE STATEMENT (AMENDED) re: pldg. ( #1 in MDL No. 3103), ( #16 in MDL No. 3103) -- Identifying Corporate Parent No Parent Corp, Non-Party/Financial Interest Celltrion Holdings, Co. for Celltrion, Inc.. Associated Cases: MDL No. 3103, WVN/1:23-cv-00089 (Gottlieb, Max) Modified on 2/6/2024 (LH). EDITED EVENT NAME AND ADDED FILING PARTIES
February 2, 2024 Filing 24 RESPONSE IN OPPOSITION (JOINT) -- (re: pldg. ( #1 in MDL No. 3103) ) Filed by Defendants Formycon AG, #et al.Samsung Bioepis Co., Ltd., Celltrion, Inc. #[Suppress List] (Attachments: #1 Exhibit 1 - SB Motion to Dismiss, #2 Exhibit 2 - RGN Request re CD Cal PI Sched, #3 Exhibit 3 - CD Cal Order re PI Sched, #4 Exhibit 4 - All Asserted Patents, #5 Proof of Service) Associated Cases: MDL No. 3103, CAC/2:24-cv-00264, WVN/1:22-cv-00061, WVN/1:23-cv-00089, WVN/1:23-cv-00094, WVN/1:23-cv-00097, WVN/1:23-cv-00106 (Traupman, Matthew) Modified on 2/6/2024 (LH). REMOVED DUPLICATE PARTY Modified on 2/7/2024 (LH). EDITED EVENT NAME
February 2, 2024 Filing 23 NOTICE OF APPEARANCE (CORRECTED) re: pldg.( #1 in MDL No. 3103), ( #13 in MDL No. 3103) Filed by Max Gottlieb on behalf of Defendant Celltrion, Inc. Associated Cases: MDL No. 3103, WVN/1:23-cv-00089 (Gottlieb, Max) Modified on 2/6/2024 (LH). EDITED EVENT NAME AND ADDED MDL LINK
January 31, 2024 Filing 22 CERTIFICATE OF SERVICE re: pldg. ( #13 in MDL No. 3103, 8 in WVN/1:23-cv-00089) Filed by Defendant Celltrion, Inc. -- Associated Cases: MDL No. 3103, WVN/1:23-cv-00089 (Gottlieb, Max)
January 26, 2024 Filing 21 CORPORATE DISCLOSURE STATEMENT re: pldg. ( #2 in MDL No. 3103), ( #1 in MDL No. 3103) -- Identifying Corporate Parent No Parent Corp. for Formycon AG. (Attachments: #1 Proof of Service) Associated Cases: MDL No. 3103, WVN/1:23-cv-00097 (Mascherin, Terri) Modified on 1/30/2024 (LH). ADDED NO PARENT CORP, FILING PARTY AND MDL LINK
January 26, 2024 Filing 20 NOTICE OF APPEARANCE re: pldg.( #2 in MDL No. 3103), ( #1 in MDL No. 3103) Filed by Terri L. Mascherin on behalf of Defendant Formycon AG (Attachments: #1 Proof of Service) Associated Cases: MDL No. 3103, WVN/1:23-cv-00097 (Mascherin, Terri) Modified on 1/31/2024 (LH). ADDED MDL LINK
January 26, 2024 Filing 19 CORPORATE DISCLOSURE STATEMENT re: pldg. ( #1 in MDL No. 3103) -- Identifying Corporate Parent Biocon Limited, Corporate Parent Biocon Biologics UK Limited, Corporate Parent Biocon Biologics Limited for BIOCON BIOLOGICS INC. (Attachments: #1 Proof of Service) Associated Cases: MDL No. 3103, WVN/1:22-cv-00061 (Mazzochi, Deanne) Modified on 1/30/2024 (LH). REMOVED DUPLICATE PARTY
January 26, 2024 Filing 18 CORPORATE DISCLOSURE STATEMENT re: pldg. ( #1 in MDL No. 3103) -- Identifying Corporate Parent Viatris Inc., Corporate Parent Mylan Inc. for Mylan Pharmaceuticals Inc. (Attachments: #1 Proof of Service) Associated Cases: MDL No. 3103, WVN/1:22-cv-00061 (Mazzochi, Deanne) Modified on 1/30/2024 (LH). REMOVED DUPLICATE PARTY
January 26, 2024 Filing 17 NOTICE OF APPEARANCE re: pldg.( #1 in MDL No. 3103) Filed by Deanne Mazzochi on behalf of Defendants/Counter Claimants BIOCON BIOLOGICS INC., #et al.Mylan Pharmaceuticals Inc. #[Suppress List] (Attachments: #1 Proof of Service) Associated Cases: MDL No. 3103, WVN/1:22-cv-00061 (Mazzochi, Deanne) Modified on 1/30/2024 (LH). REMOVED DUPLICATE PARTIERS
January 26, 2024 Filing 16 SEE CORRECTED PLEADING (re: pldg. ( #25 in MDL No. 3103)) CORPORATE DISCLOSURE STATEMENT re: pldg. ( #2 in MDL No. 3103), ( #1 in MDL No. 3103) -- Identifying Corporate Parent No Parent Corp, Non-Party/Financial Interest Celltrion Holdings, Co. for Celltrion, Inc.. (Attachments: #1 Proof of Service) Associated Cases: MDL No. 3103, WVN/1:23-cv-00089 (Gottlieb, Max) Modified on 1/30/2024 (LH). ADDED NO PARENT CORP AND MDL LINK Modified on 2/5/2024 (LH). ADDED NOTATION
January 26, 2024 Filing 15 CORPORATE DISCLOSURE STATEMENT re: pldg. ( #1 in MDL No. 3103) -- Identifying Corporate Parent Samsung Biologics Co., Ltd, Non-Party/Financial Interest Samsung Electronics Co., Ltd., Non-Party/Financial Interest Samsung C&T Corporation for Samsung Bioepis Co., Ltd.. (Attachments: #1 Exhibit A - Corporate Entities, #2 Proof of Service) Associated Cases: MDL No. 3103, WVN/1:23-cv-00094, WVN/1:23-cv-00106 (Traupman, Matthew) Modified on 1/30/2024 (LH). REMOVED DUPLICATE PARTY
January 26, 2024 Filing 14 NOTICE OF APPEARANCE re: pldg.( #1 in MDL No. 3103), Filed by Matthew A Traupman on behalf of Defendant Samsung Bioepis Co., Ltd., (Attachments: #1 Exhibit A - Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 3103, WVN/1:23-cv-00094, WVN/1:23-cv-00106 (Traupman, Matthew) Modified on 1/30/2024 (LH). REMOVED DUPLICATE PARTY
January 26, 2024 Filing 13 SEE CORRECTED PLEADING (re: pldg. ( #23 in MDL No. 3103)) NOTICE OF APPEARANCE re: pldg.( #2 in MDL No. 3103) Filed by Max Gottlieb on behalf of Defendant Celltrion, Inc. Associated Cases: MDL No. 3103, WVN/1:23-cv-00089 (Gottlieb, Max) Modified on 2/5/2024 (LH). ADDED NOTATION
January 26, 2024 Filing 12 ORAL ARGUMENT STATEMENT re: pldg. ( #1 in MDL No. 3103) Filed by Plaintiff Regeneron Pharmaceuticals, Inc. (Attachments: #1 Exhibit A Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 3103, CAC/2:24-cv-00264, WVN/1:22-cv-00061, WVN/1:23-cv-00089, WVN/1:23-cv-00094, WVN/1:23-cv-00097, WVN/1:23-cv-00106 (Berl, David) Modified on 1/31/2024 (LH). REMOVED DUPLICATE PARTIES AND DUPLICATE ATTACHMENT NAMES
January 26, 2024 Filing 11 CORPORATE DISCLOSURE STATEMENT re: pldg. ( #1 in MDL No. 3103) -- Identifying Corporate Parent No Parent Corp. for Regeneron Pharmaceuticals, Inc. (Attachments: #1 Exhibit A Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 3103, CAC/2:24-cv-00264, WVN/1:22-cv-00061, WVN/1:23-cv-00089, WVN/1:23-cv-00094, WVN/1:23-cv-00097, WVN/1:23-cv-00106 (Berl, David) Modified on 1/30/2024 (LH). REMOVED DUPLICATE PARTIES AND ATTACHMENT NAMES
January 26, 2024 Filing 10 NOTICE OF APPEARANCE re: pldg. ( #2 in MDL No. 3103), ( #1 in MDL No. 3103) Filed by Siegmund Y. Gutman on behalf of Defendant Amgen, Inc. Associated Cases: MDL No. 3103, CAC/2:24-cv-00264 (Gutman, Siegmund) Modified on 1/31/2024 (LH). ADDED MDL LINKS
January 26, 2024 Filing 9 NOTICE OF APPEARANCE re: pldg.( #1 in MDL No. 3103) Filed by David Isaac Berl on behalf of Plaintiff Regeneron Pharmaceuticals, Inc. (Attachments: #1 Exhibit A Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 3103, CAC/2:24-cv-00264, WVN/1:22-cv-00061, WVN/1:23-cv-00089, WVN/1:23-cv-00094, WVN/1:23-cv-00097, WVN/1:23-cv-00106 (Berl, David) Modified on 1/30/2024 (LH). REMOVED DUPLICATE PARTIES AND ATTACHMENT NAMES
January 26, 2024 Filing 8 CORPORATE DISCLOSURE STATEMENT re: pldg. ( #2 in MDL No. 3103), ( #1 in MDL No. 3103) -- Identifying Corporate Parent No Parent Corp. for Amgen, Inc. Associated Cases: MDL No. 3103, CAC/2:24-cv-00264 (Gutman, Siegmund) Modified on 1/31/2024 (LH). ADDED MDL LINK, PARENT CORP AND FILING PARTY
January 12, 2024 Filing 7 ***TEXT ONLY ENTRY***MINUTE ORDER (re: pldg. ( #3 in MDL No. 3103) ) Plaintiff has moved to expedite consideration of its motion to transfer. The Panel considers all motions in due course and is not persuaded to depart from its long-standing practice. The motion for expedited consideration is DENIED. This matter will be set for the March 28, 2024 Hearing Session Order. Signed by Clerk of the Panel Tiffaney D. Pete on 1/12/2024. Associated Cases: MDL No. 3103, CAC/2:24-cv-00264, WVN/1:22-cv-00061, WVN/1:23-cv-00089, WVN/1:23-cv-00094, WVN/1:23-cv-00097, WVN/1:23-cv-00106 (DLD) Modified on 1/12/2024 (DLD).
January 12, 2024 Filing 6 ***TEXT ONLY NOTICE***NOTICE OF FILING AND PUBLICATION OF BRIEFING SCHEDULE re: pldg. ( #1 in MDL No. 3103) BRIEFING SCHEDULE IS SET AS FOLLOWS: Notices of Appearance due on or before 1/26/2024. Corporate Disclosure Statements due on or before 1/26/2024. Responses due on or before 2/2/2024. Reply, if any, due on or before 2/9/2024. In their briefs, the parties should address what steps they have taken to pursue alternatives to centralization (including, but not limited to, engaging in informal coordination of discovery and scheduling, and seeking Section 1404 transfer of one or more of the subject cases). #Appearance forms (JPML form 18) and #Corporate Disclosure forms can be downloaded from our website. Important: A Corporate Disclosure Form, if required, must be filed, even if one has previously been filed in this MDL.Please visit the #CM/ECF Filing Guidelines & Forms page of our website for additional information.Attorneys must be registered to file in the JPML. Please visit our website for #Registration Information.Signed by Clerk of the Panel Tiffaney D. Pete on 1/12/2024. Associated Cases: MDL No. 3103, CAC/2:24-cv-00264, WVN/1:22-cv-00061, WVN/1:23-cv-00089, WVN/1:23-cv-00094, WVN/1:23-cv-00097, WVN/1:23-cv-00106 (DLD)
January 12, 2024 Filing 5 MDL Number 3103 Assigned -- MOTION FOR TRANSFER ACCEPTED FOR FILING re: pldg. ( #1 in Pending No. 5) Associated Cases: Pending No. 5, CAC/2:24-cv-00264, WVN/1:22-cv-00061, WVN/1:23-cv-00089, WVN/1:23-cv-00094, WVN/1:23-cv-00097, WVN/1:23-cv-00106 (DLD)
January 12, 2024 Filing 4 MOTION TO TRANSFER (CORRECTED) -- (re: pldg. #1 ) Correcting the following items: Proof of service, -- Filed by: Plaintiff Regeneron Pharmaceuticals, Inc. (Berl, David)
January 11, 2024 Filing 3 MOTION TO EXPEDITE (re: pldg. #1 in MDL No. 3103) Filed by David Isaac Berl on behalf of Plaintiff Regeneron Pharmaceuticals, Inc. (Attachments: #1 Proof of Service) Associated Cases: Pending No. 5, CAC/2:24-cv-00264, WVN/1:22-cv-00061, WVN/1:23-cv-00089, WVN/1:23-cv-00094, WVN/1:23-cv-00097, WVN/1:23-cv-00106 (Berl, David) Modified on 1/12/2024 (DLD). REMOVED DUPLICATE PARTIES Modified on 1/16/2024 (DLD). REMOVED DUPLICATE ATTACHMENT NAME AND ADDED MDL LINK.
January 11, 2024 Filing 2 MOTION TO TRANSFER (AMENDED) (re: pldg. #1 ) -- 5 Additional Action(s) -- from West Virginia Northern District Court (1:22-cv-00061,1:23-cv-00089,1:23-cv-00094,1:23-cv-00097,1:23-cv-00106) Filed by: Plaintiff Regeneron Pharmaceuticals, Inc. (Berl, David)
January 11, 2024 Filing 1 MOTION TO TRANSFER (INITIAL MOTION) with Brief in Support. -- 6 Action(s) -- from California Central District Court (2:24-cv-00264) -- from West Virginia Northern District Court (1:22-cv-00061,1:23-cv-00089,1:23-cv-00094,1:23-cv-00097,1:23-cv-00106) Suggested Transferee Court: Northern District of West Virginia Filed by: Regeneron Pharmaceuticals, Inc. (Attachments: #1 Brief in Support of Motion, #2 Schedule of Actions, #3 Proof of Service, #4 Exhibit 1 Complaint 22-cv-00061, #5 Exhibit 2 Complaint 23-cv-00089, #6 Exhibit 3 Complaint 23-cv-00094, #7 Exhibit 4 Complaint 23-cv-00106, #8 Exhibit 5 Complaint 23-cv-00097, #9 Exhibit 6 Complaint 24-cv-00264, #10 Exhibit 7 ND WVA Order Setting Briefing Schedule)(Berl, David) Modified on 1/12/2024 (DLD). ADDED ADDITIONAL CASES AND REMOVE DUPLICATE ATTACHMENT NAMES

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Judicial Panel on Multidistrict Litigation's Electronic Court Filings (ECF) System

Search for this case: IN RE: Aflibercept Patent Litigation
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Liaison Counsel for Plaintiffs
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Liaison Counsel for Defendants
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?